Back to archive

Luzhou Laojiao Investment Quality Review (000568.SZ)

Luzhou Laojiao: WATCHLIST, quality 77/100, price/base FV 1.41, base FV 61.68 CNY.

Final Signal
Watch
Quality Score
77
Current Price
CNY 86.8
Conservative Fair Value
CNY 61.68
Base Fair Value
CNY 61.68
Report Date
2026-07-23
Data Timestamp
2026-07-22 22:05 UTC
china-aconsumer-staplesbeveragehigh-fcfcapital-return

Luzhou Laojiao Investment Quality Review (000568.SZ)

Data timestamp: 2026-07-22 22:05 UTC
Quality score: 77/100 Valuation position: price/base fair value 1.41 Final signal: WATCHLIST

Core View

Luzhou Laojiao is rated WATCHLIST in this review. The report keeps the stock on the watchlist: business quality may be investable, but price and evidence do not yet support a buy signal. Current price is 86.80 CNY; conservative and base fair values are 61.68 CNY and 61.68 CNY per share. Price/base FV is 1.41, which is above fair value and short of downside protection.

The reviewed business exposure is high-end and sub-high-end baijiu products with regional channel depth. The Chinese source anchors the conclusion in repeatable free cash flow, balance-sheet resilience, governance and capital-allocation evidence, then applies a valuation discount before deciding whether the stock deserves action. This English memo keeps the same signal, fair-value range, evidence limits, risk controls and review discipline.

Business Breakdown

The source report uses a five-year revenue and cash-flow view rather than a single-year extrapolation. The key economic question is whether the disclosed business mix can keep converting revenue into free cash flow through a normal cycle. Latest reported FCF in the financial table is 51.9 RMB 100m; that cash-flow anchor drives the valuation range more than headline revenue growth.

Segment profit, gross margin and management outlook are treated conservatively when disclosure is incomplete. A stronger product cycle, channel recovery, AI monetization, premiumization, or international growth can lift the watchlist only after it shows up in verified FCF, margin and per-share value evidence.

Business Quality Score

Quality is scored at 77/100. The scorecard covers business model quality, moat, repeatable cash flow, capital return, balance-sheet resilience, growth quality, and management/accounting. A high score does not by itself create a buy signal: the report still requires valuation support, a margin of safety and no unresolved material evidence gaps.

The main positive evidence is the existence of a five-year financial baseline with positive or analyzable cash-flow history and a balance sheet that can be bridged to common-equity value. The main constraints are the same as in the Chinese report: cyclical or regulatory exposure, disclosure depth, FCF durability, capital-allocation quality, incentive dilution, and whether current market expectations already price in too much improvement.

Financial Audit

The audit uses the complete fiscal years shown below, with the same quote currency, financial currency, FX treatment and risk-free-rate date as the Chinese source report. FCF is the primary valuation anchor; net profit, OCF, capex, FCF/Revenue and FCF/Net Income are used to check cash conversion rather than to create separate price targets.

Year Revenue Net Profit OCF Capex FCF ROE ROIC FCF/Revenue FCF/Net Income
2025 257.3 RMB 100m 108.3 RMB 100m 71.2 RMB 100m 19.3 RMB 100m 51.9 RMB 100m 22.7% 18.2% 20.2% 0.48
2024 312.0 RMB 100m 134.7 RMB 100m 191.8 RMB 100m 11.9 RMB 100m 179.9 RMB 100m 30.4% 23.6% 57.7% 1.34
2023 302.3 RMB 100m 132.5 RMB 100m 106.5 RMB 100m 15.0 RMB 100m 91.5 RMB 100m 35.1% 27.5% 30.3% 0.69
2022 251.2 RMB 100m 103.7 RMB 100m 82.6 RMB 100m 10.4 RMB 100m 72.3 RMB 100m 33.3% 27.8% 28.8% 0.70
2021 206.4 RMB 100m 79.6 RMB 100m 77.0 RMB 100m 19.8 RMB 100m 57.2 RMB 100m 31.1% 25.9% 27.7% 0.72

ROIC is not invented when the available structured fields cannot reliably reconstruct invested capital. When FCF/Net Income weakens or capex absorbs more operating cash, normalized FCF and the quality score must be revisited.

Balance Sheet Bridge

Year Cash Current Financial Assets Non-current Financial Assets Total Debt Net Cash / Net Debt
2025 273.4 RMB 100m 4.3 RMB 100m 4.8 RMB 100m 67.2 RMB 100m 206.2 RMB 100m
2024 335.8 RMB 100m 2.4 RMB 100m 4.1 RMB 100m 95.8 RMB 100m 240.0 RMB 100m
2023 259.5 RMB 100m 1.8 RMB 100m 4.0 RMB 100m 116.0 RMB 100m 143.5 RMB 100m
2022 177.6 RMB 100m 1.5 RMB 100m 11.4 RMB 100m 62.9 RMB 100m 114.7 RMB 100m
2021 135.1 RMB 100m 1.1 RMB 100m 3.6 RMB 100m 41.2 RMB 100m 94.0 RMB 100m

Cash, financial assets and debt are handled before common-equity fair value. Cash and liquid assets receive haircuts where composition or availability is uncertain; debt, leases, senior claims, dilution and contingent liabilities reduce value first.

Shareholder Returns

The Chinese report checks dividend yield, payout ratio, dividends/FCF, buybacks and dilution as capital-allocation evidence. These items are not double-counted as extra fair value. Dividends matter only when covered by repeatable FCF; buybacks matter only when they reduce share count at prices below intrinsic value; incentives matter when they improve or dilute ordinary shareholder economics.

This review does not upgrade the signal for a headline dividend or a recognizable brand. Shareholder return quality must reinforce the FCF valuation, not substitute for it.

Valuation

The valuation uses normalized FCF as the main anchor and adjusts for cash, financial assets, debt, dilution and other senior claims. Scenario outputs from the Chinese source are:

Scenario Fair Equity Value Fair Value / Share Price/FV Weight Required Follow-up
Conservative 907.8 RMB 100m 61.68CNY 1.41 30% FCF must not fall materially below the conservative anchor.
Base 907.8 RMB 100m 61.68CNY 1.41 50% Revenue, margin and capital-return evidence must remain intact.
Optimistic 1178.2 RMB 100m 80.05CNY 1.08 20% Growth or quality rerating must be verified and cannot bypass the valuation cap.

Base fair value is 61.68 CNY per share. The 2x discipline requires price/base FV at or below 0.50 and support from at least two independent valuation anchors. With price/base FV at 1.41, the report keeps valuation discipline ahead of narrative quality.

Buy And Tracking Discipline

Current action: WATCHLIST. A buy review requires price/base FV below 0.70, quality score no lower than 75, intact FCF conversion, no adverse balance-sheet shift, and stronger evidence that the market fear is temporary rather than structural. The 2x condition requires price/base FV below 0.50 plus a recheck of conservative FV.

Tracking priorities are revenue trend, FCF/Net Income, OCF/Net Income, ROIC or capital-return evidence, net cash or debt, financial-asset marks, dividend coverage, buyback price, incentive dilution, related-party risk and management outlook. If two reporting periods show weaker cash conversion, rising debt, financial-asset impairment, harmful dilution or worsening regulatory/competitive pressure, fair value and signal must be cut.

Risks To Recheck

Key risks are FCF durability, balance-sheet bridge reliability, shareholder-return quality, governance or accounting deterioration, and whether growth converts into per-share free cash flow. For high-multiple companies, even a good business can remain unattractive if current price already embeds optimistic growth and margin assumptions.

A downgrade is required if FCF/Net Income falls below the report threshold for two periods, debt or financial-asset impairments weaken downside protection, regulatory or competitive pressure worsens, or dividends, buybacks and incentives dilute ordinary shareholders instead of compounding value.

Sources

The evidence set follows the Chinese source report: market quote and share-count data, five-year financial baseline, official annual or interim filings, governance and incentive disclosures, dividends and buybacks, risk-free-rate references, and currency alignment. The Chinese source file is 2026-07-23/stock-audit-000568.SZ-2026-07-23.md, with source hash 857eec4928bc6067417040bfd6a78f34f192e123592f7423d5216594b9bb5a11.

Research note: This memo is for personal research only and is not personalized investment advice.

Disclaimer

This article is for research records and educational discussion only. It is not investment advice. Investing involves risk; readers should make independent decisions and bear the results themselves.